Functional Correlates of Serotonin 5-HT₁ Recognition Sites

References

• Andrade R., Malenka R. C., Nicoll R. A. A G protein couples serotonin and GABA receptors to the same channels in hippocamps. Science 1986; 234: 1261–65
   PubMed Web of Science ®Google Scholar
• Blurton P. A., Wood M. D. Identification of multiple binding sites for [3H]-5-hydroxytryptamine in the rat CNS. J. Neurochem., 46: 1392–1398
   Google Scholar
• Bradley P. B., Engel G., Feniuk J. R., Fozard P. P.A., Humphrey D. N., Middlemiss E. J., Mylecharane E. J., Richardson B. P., Saxena P. R. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacol. 1986; 25: 563–576
   PubMed Web of Science ®Google Scholar
• Buchheit K. H., Engel G., Hagenbach A., Hoyer D., Kalkman H. O., Seiler M. P. The rat isolated stomach fundus strip, a model for 5-HT1C receptors. Br. J. Pharmacol. 1986; 88: 367P
   Google Scholar
• Chaput Y., Blier P., de Montigny C. In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals. J. Neurosci. 1986; 6(10)2796–2801
   Google Scholar
• Charlton K. G., Bond R. A., Clarke D. E. An inhibitory prejunctional “5-HT1-like” receptor in the isolated perfused rat kidney: apparent distinction from the 5-HT1B 5-HT1B and 5-HT1C subtypes. Naunyn-Schmiedeberg's Arch. Pharmacol. 1986; 332: 8–15
   Google Scholar
• Clineschmidt B. V., Reiss D. R., Pettibone D. J., Robinson J. L. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus. J. Pharmacol. Exp. Ther. 1985; 235: 696–708
   PubMedGoogle Scholar
• Cohen M. L., Wittenauer L. A. Further evidence that the serotonin receptor in the rat stomach fundus is not 5-HT1A or 5-HT1B. Life Sci. 1985; 38: 1–5
   Google Scholar
• Cohen M. L., Wittenauer L. A. Relationship between serotonin and tryptamine receptors in the rat stomach fundus. J. Pharmacol. Exp. Ther. 1985; 233: 75–79
   Google Scholar
• Conn P. J., Sanders-Bush E., Hoffmann B. J., Hartig P. R. A unique serotonin receptor in choroid plexus is linked to phosphatidylinositol turnover. Proc. Natl. Acad. Sci. USA 1986; 83: 4086–4088
   PubMed Web of Science ®Google Scholar
• Conn P. J., Sanders-Bush E. Agonist-Induced phosphoinositide hydrolysis in choroid plexus. J. Neurochem. 1986; 47: 1754–1760
   PubMedGoogle Scholar
• Connor H. E., Feniuk W., Humphrey P. P.A., P M. J. 5-Carboxamido-tryptamine is a selective agonist at 5-HT receptors mediating vasodilation and tachycardia in anaesthetized cats. Br. J. Pharmacol. 1986; 87: 417–426
   Google Scholar
• De Vivo M., Maayani S. Inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT receptor agonists. Eur. J. Pharmacol. 1985; 119: 231–234
   Google Scholar
• De Vivo M., Maayani S. Characterization of the 5-hydroxytryptamine1A -receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea-pig and rat hippocampal membranes. J. Pharmacol. Exp. Ther. 1986; 238: 248–253
   PubMed Web of Science ®Google Scholar
• Doods H. N., Kalkman H. O., de Jonge A., Thoolen M. J.M.C., Wilffert B., Timmermans P. B.M.W.M., Van Zwieten P. A. Differential selectivities of RU 24969 and 8-OH-DPAT for the purported 5-HT1A and 5-HT1B binding sites. Correlation between 5-HT1A affinity and hypotensive activity. Eur. J. Pharmacol. 1985; 112: 363–370
   PubMedGoogle Scholar
• Engel G, Göllert-Schweinitzer E., Schlicker E., Sistonen L., Stadler P. A. Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves. Naunyn-Schmiedeberg's Arch. Pharmacol. 1983; 324: 116–124
   Google Scholar
• Engel G., Göthert M., Hoyer D., Schlicker E., Hillenbrand K. Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn-Schmiedeberg's Arch. Pharmacol. 1986; 332: 1–7
   Google Scholar
• Ennis C. Is the 5-HT receptor which modulates 3H-dopamine release in rat striatum a 5-HT1A receptors. Brit. J. Pharmacol.
   Google Scholar
• Feniuk W., Humphrey P. P.A., Perren M. J., Watts A. D. A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein. Evidence for different receptor types obtained by use of selective agonists and antagonists. Br. J. Pharmacol. 1985; 86: 697–704
   Google Scholar
• Fozard J. R. Functional correlates of 5-HT1 recognition sites. Trends Pharmacol. Sci. 1983; 4: 288–289
   Google Scholar
• Fozard J. R. Neuronal 5-HT receptors in the periphery. Neuropharmacol. 1984; 23: 1473–1486
   PubMed Web of Science ®Google Scholar
• Fozard J. R. MDL 72222, a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 1984; 326: 36–44
   Google Scholar
• Fozard J. R., Kilbinger H. 8-OH-DPAT inhibits transmitter release from guinea-pig enteric cholinergic neurones by activating 5-HT1A receptors. Br. J. Pharmacol. 1985; 86: 601P
   PubMedGoogle Scholar
• Fozard J. R., Mir A. K., Middlemiss D. N. The cardiovascular response to 8-Hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis. J. Cardiovasc. Pharmacol. 1987; 9: 328–347
   PubMed Web of Science ®Google Scholar
• Fozard J. R. 5-HT3 receptors and cytotoxic drug-induced vomiting. TIPS 1987; 8: 44–45
   Web of Science ®Google Scholar
• Gaddum J. H., Picarelli Z. P. Two kinds of tryptamine receptor. Br. J. Pharmacol. Chemother. 1957; 12: 323–328
   PubMed Web of Science ®Google Scholar
• Glennon R. A. Central serotonin receptors as targets for drug research. J. Med. Chem. 1987; 30: 1–12
   PubMedGoogle Scholar
• Gozlan H., El Mestikawy S., Pichat L., Glowinski J., Hamon M. Identification of presynaptic serotonin autoreceptors by a new ligand: 3H-PAT. Nature (Lond.) 1983; 305: 140–142
   PubMed Web of Science ®Google Scholar
• Hall M. D., El Mestikawy S., Emerit M. B., Pichat L., Hamon M., Gozlan H. [3H]8-Hydroxy-2-(di-n-propylamino) tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the brain. J. Neurochem. 1985; 44: 1685–1696
   PubMed Web of Science ®Google Scholar
• Hagenbach A., Hoyer D., Kalkman H. O., Seiler M. P. N,N-dipropyl 5-hydroxytryptamine (DP-5CT), an extremely potent and selective 5-HT1A agonist. Br. J. Pharmacol. 1986; 87: 136P
   Google Scholar
• Heuring R. E., Peroutka S. J. Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J. Neurosci. 1987; 7: 894–903
   PubMed Web of Science ®Google Scholar
• Hoyer D., Engel G., Kalkman H. O. Characterization of the 5-HT recognition site in rat brain: binding studies with [125IBI] iodocyanopindolol. Eur. J. Pharmacol. 1985; 118: 1–12
   PubMedGoogle Scholar
• Hoyer D., Engel G., Kalkman H. O. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]-8-OH-DPAT, (-)[125I] iodocyanopindolol, [3H]-mesulergine and [3H]ketanserin. Eur. J. Pharmacol. 1985; 118: 13–23
   PubMed Web of Science ®Google Scholar
• Hoyer D., Pazos A., Probst A., Palacios J. M. Serotonin receptors in the human brain. I Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res. 1986; 376: 85–96
   PubMed Web of Science ®Google Scholar
• Hoyer D., Pazos A., Probst A., Palacios J. M. Serotonin receptors in the human brain II. Chracterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res. 1986; 376: 97–107
   PubMedGoogle Scholar
• Hoyer D., Srivatsa S., Pazos A., Engel G., Palacios J. M. [125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes comparison with [3H]mesulergine and [3H]5-HT binding. Neurosci. Lett. 1986; 69: 269–274
   Google Scholar
• Kalkman H. O., Hagenbach A., Seiler M. P. Serotonin (5-HT) receptors in the rat stomach fundus characterized as 5-HT1C. Naunyn Schmiedeberg's Arch. Pharmacol. 1986; 332: R81
   Google Scholar
• Kalkman H. O., Engel G., Hoyer D. Inhibition of 5-carboxamidotryptamine-induced relaxation of guinea-pig ileum correlates with [125I]LSD binding. Eur. J. Pharmacol. 1986; 129: 139–145
   PubMedGoogle Scholar
• Kilbinger H., Pfeuffer-Friedrich I. Two types of receptors for 5-hydroxytryptamine on the cholinergic nerves of the guinea-pig myenteric plexus. Br. J. Pharmacol. 1985; 85: 529–539
   PubMed Web of Science ®Google Scholar
• Leysen J. Problems in in vitro receptor binding studies and identification and role of serotonin receptor sites. Neuropharmacol. 1984; 23: 247–254
   Google Scholar
• Markstein R., Hoyer D., Engel G. 5-HT1A -receptors mediate stimulation of adenylate cyclase in rat hippocampus. Naunyn-Schmiedeberg's Arch. Pharmacol. 1986; 333: 335–341
   Google Scholar
• Martin L. L., Sanders-Bush E. Comparison of the pharmacological characteristics of 5-HT1 and 5-HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release. Naunyn-Schmiedeberg's Arch. Pharmacol. 1982; 321: 165–170
   Google Scholar
• Maura G., Roccataglia E., Raiteri M. Serotonin autoreceptor in rat hippocampus: Pharmacological characterization as a subtype of the 5-HT1 receptor. Naunyn-Schmiedeberg's Arch. Pharmacol. 1986; 334: 323–326
   Google Scholar
• Maura G., Raiteri M. Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release. Eur. J. Pharmacol. 1986; 129: 333–337
   PubMed Web of Science ®Google Scholar
• Middlemiss D. N. Multiple 5-hydroxytryptamine receptors in the central nervous system of the rat. Presynaptic receptors: Mechanisms and functions, J. De Belleroche. Ellis Horwood. Pub., Chichester 1982; 47–74
   Google Scholar
• Middlemiss D. N. 8-hydroxy-2-(di-n-propylamino)tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in autoreceptor and the [3H]5-HT recognition site. Naunyn-Schmiedeberg's Arch. Pharmacol. 1984; 327: 18–22
   Google Scholar
• Middlemiss D. N. Functional correlates of the subtypes of the 5-HT1 recognition site. Trends Pharmacol. Sci. 1986; 7: 52–53
   Google Scholar
• Müller-Schweinitzer E., Engel G. Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery. Naunyn-Schmiedeberg's Arch. Pharmacol. 1983; 324: 287–292
   Google Scholar
• Palacios J. M., Markstein R., Pazos A. Serotonin-1C sites in the choroid plexus are not linked in a stimulatory or inhibitory way to adenylate cyclase. Brain Res. 1986; 380: 151–154
   Google Scholar
• Pazos A., Hoyer D., Palacios J. M. Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors, in porcine and human cortex; Evidence for species differences on brain serotonin-2 receptors. Eur. J. Pharmacol. 1984; 106: 531–538
   PubMedGoogle Scholar
• Pazos A., Hoyer D., Palacios J. M. The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur. J. Pharmacol. 1984; 106: 539–546
   PubMed Web of Science ®Google Scholar
• Pazos A., Palacios J. M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 1985; 346: 205–230
   PubMed Web of Science ®Google Scholar
• Pazos A., Engel G, Palacios J. M. Beta-adrenoceptor blocking agents recognize a subpopulation of serotonin receptors in brain. Brain Res. 1985; 343: 403–408
   Google Scholar
• Pedigo N. W., Yamamura H. I., Nelson D. L. Descrimination of multiple [3H]5-hydroxytryptamine-binding sites by the neuroleptic spiperone in rat brain. J. Neurochem. 1981; 36: 220–226
   PubMed Web of Science ®Google Scholar
• Peroutka S. J., Lebovitz R. M., Snyder S. H. Serotonin receptor binding sites affected differentially by guanine nucleotides. Mol. Pharmacol. 1979; 16: 700–708
   PubMed Web of Science ®Google Scholar
• Peroutka S. J., Snyder S. H. Multiple seotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergicacid diethylamide and [3H]spiperoperidol. Mol. Pharmacol. 1979; 16: 687–699
   PubMed Web of Science ®Google Scholar
• Peroutka S. J., Lebovitz R. M., Snyder S. H. Two distinct central serotonin receptors with different physiological functions. Science 1981; 212: 827–829
   PubMed Web of Science ®Google Scholar
• Peroutka S. J. 5-HT1 receptor sites and functional correlates. Neuropharmacol. 1984; 23: 1487–1492
   PubMed Web of Science ®Google Scholar
• Peroutka S. J. Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B and 5-HT1C binding sites in rat frontal cortex. J. Neurochem. 1986; 47: 529–540
   PubMed Web of Science ®Google Scholar
• Peroutka S. J., Huang S., Allen G. S. Canine basilar artery contractions mediated by 5-hydroxytryptamine1A -receptors. J. Pharmacol. Exp. Ther. 1986; 237: 901–906
   Google Scholar
• Pfeuffer-Friedrich I., Kilbinger H. The effects of LSD in the guinea-pig ileum. Inhibition of acetylcholine release and stimulation of smooth muscle. Naunyn-Schmiedeberg's Arch. Pharmacol. 1985; 331: 311–315
   Google Scholar
• Raiteri M., Maura G., Bonanno G., Pittaluga A. Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum. J. Pharmacol. Exp. Ther. 1986; 237: 644–648
   PubMed Web of Science ®Google Scholar
• Richardson B. P., Engel G., Donatsch P., Stadler P. A. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 1985; 316: 126–131
   PubMed Web of Science ®Google Scholar
• Richardson B. P., Engel G. The pharmacology and function of the 5-HT3 receptors. TINS, 9: 424–428
   Google Scholar
• Robaut C., Fillion M. P., Dufois S., Fayolle-Bauguen C., Rouselle J. C., Gillet G., Benkirane S., Fillion G. Multiple high affinity binding sites for 5-hydroxytryptamine: a new class of sites distinct from 5-HT1 and S2. Brain Res. 1986; 346: 250–262
   Google Scholar
• Saxena P. R., Mylecharane E. J., Heiligers J. Analysis of the heart rate effects of 5-hydroxytryptamine in the cat: mediation of tachycardia by 5-HT1-like receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 1985; 330: 121–129
   Google Scholar
• Shenker A., Maayani S., Weinstein H., Green J. P. Two 5-HT receptors linked to adenylate cyclase in guinea pig hippocampus are discriminated by 5-hydroxytryptamine-mine and spiperone. Eur. J. Pharmacol. 1985; 109: 427–429
   PubMedGoogle Scholar
• Sprouse J. S., Aghajanian G. K. (-) Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. Eur. J. Pharmacol. 1986; 128: 295–298
   Google Scholar
• Sprouse J. S., Aghajanian G. K. Electrophysiological responses of serotonergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse. 1987; 1: 3–9
   PubMed Web of Science ®Google Scholar
• Taylor E. W., Duckles S. P., Nelson D. L. Dissociation constants of serotonin agonists in the canine basilar artery correlate to Ki values at the 5-HT1A binding site. J. Pharmacol. Exp. Ther. 1986; 236: 118–125
   PubMed Web of Science ®Google Scholar
• Trevethick M. A., Feniuk W., Humphrey P. P.A. 5-hydroxytryptamine-induced relaxation of neonatal procine vena cava in vitro. Life Sci. 1984; 35: 477–486
   Google Scholar
• Trevethick M. A., Feniuk W., Humphrey P. P.A. 5-Carboxamidotryptamine: a potent agonist mediating relaxation and elevation of cyclic AMP in the isolated neonatal porcine vena cava. Life Sci. 1986; 1521–1528
   Google Scholar
• Tricklebank M. D. The behavioural response to 5-HT receptor agonists and subtypes of the central 5-HT receptor. Trends Pharmacol. Sci. 1985; 6: 403–407
   Google Scholar
• Tricklebank M. D., Middlemiss D. N., Neill J. Pharmacological analysis of the behavioural and thermoregulatory effects of the putative 5-HT1 receptor agonist, RU 24969, in the rat. Neuropharmacol. 1986; 25: 877–886
   Google Scholar
• Weiss S., Sebben M., Kemp D. E., Bockaert J. Serotonin 5-HT1 receptors mediate inhibition of cyclic AMP production in neurons. Eur. J. Pharmacol. 1986; 120: 227–230
   PubMed Web of Science ®Google Scholar
• White F. J. Comparative effects of LSD and lisuride: clues to specific hallucinogenic drug actions. Pharmacol. Biochem. Behav. 1986; 24: 365–379
   Google Scholar
• Yagaloff K. A., Hartig P. R. [125I]lodo-LSD binds to a novel 5-HT site on rat choroid plexus epithelial cells. J. Neurosci. 1985; 5: 3178–3183
   Google Scholar
• Yagaloff K. A., Hartig P. R. Solubilization and characterization of the serotonin 5-HT1C site from pig choroid plexus. Mol. Pharmacol. 1986; 29: 120–125
   PubMed Web of Science ®Google Scholar